Notice of Extraordinary General Meeting in Moberg Pharma AB (publ)
Shareholders in Moberg Pharma AB (publ), reg. no. 556697-7426 (the “Company”), are hereby convened to the Extraordinary General Meeting on 9 October 2023 at 09:30 on Advokatfirman Schjødt, Hamngatan 27 in Stockholm.Attendance at the Extraordinary General MeetingShareholders who wish to participate in the Extraordinary General Meeting must: · be recorded in the share register maintained by Euroclear Sweden AB (“Euroclear”) on 29 September 2023, and · notify their intention to participate no later than 3 October 2023. Notice of participation is made through regular mail to Moberg